Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
7 hedge funds and large institutions have $427K invested in Yield10 Bioscience, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 5 closing their positions.
30% less funds holding
Funds holding: 10 → 7 (-3)
32% less capital invested
Capital invested by funds: $628K → $427K (-$201K)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell & Co
New York
|
+$344K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$13.8K |
| 3 |
Morgan Stanley
New York
|
+$1.24K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$1.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$100K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$29K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$18K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$10K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
1
Cannell & Co
New York
| $200K | +$344K | +2,214 | New |
|
2
BlackRock
New York
| $142K | – | – | – |
|
|
BC
3
Birchview Capital
Burlington,
Vermont
| $71K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $12K | +$13.8K | +89 | +207% |
|
|
HDIM
5
Hanson & Doremus Investment Management
Burlington,
Vermont
| $1K | – | – | – |
|
|
6
Morgan Stanley
New York
| $1K | +$1.24K | +8 | New |
|
|
7
Renaissance Technologies
New York
| – | -$100K | -607 | Closed |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$29K | -175 | Closed |
|
|
9
Vanguard Group
Malvern,
Pennsylvania
| – | -$18K | -108 | Closed |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$16K | -97 | Closed |
|
|
11
Geode Capital Management
Boston,
Massachusetts
| – | -$10K | -62 | Closed |
|
|
12
Victory Capital Management
San Antonio,
Texas
| – | +$1.09K | +7 | New |
|
YTEN Hedge Fund Activity: Q1 2020 in Review
7 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q1 2020, worth a combined $427K — down 32% from $628K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of YTEN and 3 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Cannell & Co, opening a new position worth an estimated $344K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $100K sold.
- 7 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q1 2020, down from 10 in Q4 2019.
- Funds reported $427K of Yield10 Bioscience, Inc. Common Stock stock for Q1 2020, down 32% quarter-over-quarter.
- 3 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q1 2020 and 5 closed out, a net change of -2 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q1 2020 was Cannell & Co, an estimated $344K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q1 2020 was Renaissance Technologies, an estimated $100K sold.
Based on aggregated 13F filings for Q1 2020.